Skip to search formSkip to main contentSkip to account menu

bouchardatine

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indole Alkaloids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity
Non‐alcoholic hepatic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome in the liver and non‐alcoholic… 
2019
2019
Bouchardatine analogue alleviates NAFLD/NASH in high fat fed mice via blunting ATP synthase activity.
BACKGROUND AND PURPOSE Non-alcoholic hepatic fatty liver disease (NAFLD) is a manifestation of metabolic syndrome (MetS) in liver… 
2019
2019
Bouchardatine suppresses rectal cancer in mice by disrupting its metabolic pathways via activating the SIRT1-PGC-1α-UCP2 axis.
2018
2018
Design, synthesis and biological evaluation of novel bouchardatine analogs as potential inhibitors of adipogenesis/lipogenesis in 3T3-L1 adipocytes.
2018
2018
Novel Bouchardatine Analogs as Potential Inhibitors of Adipogenesis / Lipogenesis in 3 T 3L 1 adipocytes
Inhibition of the differentiation of adipocytes and reduced lipid synthesis are efficacious approaches for treating obesity… 
2017
2017
Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis
Promoting energy metabolism is known to provide therapeutic effects for obesity and associated metabolic disorders. The present… 
2016
2016
Synthesis of bouchardatine and its derivatives with lipid-lowering effect
2015
2015
Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment.
Our recent study has shown that the natural product bouchardatine (1) can reduce the triglyceride (TG) content in 3T3-L1… 
2015
2015
Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes.
2011
2011
[Synthesis, physicochemical and pharmacological properties of pentacyclic alkaloid-analogues].
  • M. Bubenyák
  • Acta pharmaceutica Hungarica
  • 2011
  • Corpus ID: 27009155
Quinazolinocarboline rutaecarpine and evodiamine (Evodia rutaecarpa) are main alkaloid components of traditional Chinese folk… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)